Alexander Eggermont presents the results of KEYNOTE-054

Redaktion: Dr. Gerhard Emrich

Produktion: Oliver Eberhardt


Warning: Undefined property: medonline\theme\lib\templates\MoSingle::$ID in /appl/www/htdocs/medonline/web/app/themes/mydailyapplenew/templates/entry-meta-video.php on line 56

Reference:
Eggermont AMM et al., abstract CT001: Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Efficacy and safety results from the EORTC 1325-MG/Keynote 053 double-blinded phase III trial